Table 2 Summary of important methodological aspects and research questions for future studies in perinatal antimicrobial stewardship.

From: A systematic review of Perinatal Antibiotic Stewardship – where we are, where to go?

Five important methodological aspects for future studies in perinatal antimicrobial stewardship

Mother and infant belong together: Paired data collection of mother and infant by linked medical and research databases including maternal and neonatal antibiotics

Environment is key: Consider ethnically, racially and culturally diverse populations including low- and middle-income countries with a high burden of maternal and neonatal morbidity and mortality

Prospective planning for high-quality research: Strive for prospective randomized trials or adaptive multi-arm, multi-stage study designs (e.g. platform trials)

Non-inferiority aspect: Powered for safety outcomes as missed sepsis cases, delayed start of antibiotics in case of infections, morbidity and mortality (burden of disease)

Superiority aspect: Antibiotic use and long-term follow-up or proxy for clinical outcomes and/or antimicrobial resistance rates or microbiome analyses including antimicrobial resistance genes (burden of therapy)

Five important research questions for future studies in perinatal antimicrobial stewardship

Antibiotic use in pregnancy: What algorithm can accurately assess the risk of suspected maternal infections in pregnancy, and how can we ensure compliance by health care workers in prescribing empiric antibiotic therapy?

Antibiotic use in neonates: What algorithm can accurately assess the risk of suspected neonatal bacterial infections, and how can we ensure compliance by health care workers in prescribing empiric antibiotic therapy?

Antibiotic prophylaxis: How can we safely reduce perinatal antibiotic prophylaxis in specific situations and what are conditions necessary to safely administer prophylaxis for caesarean section after cord clamping?

New technologies: How can we use newer technologies for early detection of pathogens and AMR, or AI and machine learning to support diagnostic accuracy and antibiotic prescription decisions?

Effect of antibiotics: What effect has a single dose of intrapartum or postpartum antibiotics on the developing neonatal microbiome and clinical outcomes and does this effect depend on the type of antibiotic administered?

  1. AMR Antimicrobial resistance, AI artificial intelligence.